Roche's lung cancer combo treatment wins FDA approval

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 66%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Swiss drugmaker Roche Holding AG said on Thursday that its Tecentriq immunotherapy in combination with chemotherapy was approved by the U.S. Food ...

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Novartis goes after Roche asthma medicine Xolair with new drugNovartis said it is pushing ahead with a late-stage study of its experimental drug ligelizumab after announcing the medicine outperformed Roche's ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Roche drops Alzheimer drug trials after setbackRoche Holding will halt two late-stage clinical trials of its crenezumab drug in early Alzheimer's disease after an interim analysis indicated it ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Samsung Bioepis-Merck biosimilar to Roche's Herceptin wins FDA nodThe U.S. Food and Drug Administration said on Friday it had approved a biosimilar to Roche Holding AG's blockbuster breast cancer treatment, ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Immunomedics' cancer treatment fails to win accelerated approval from the FDAREUTERS: Immunomedics Inc said on Thursday the U.S. Food and Drug Administration declined to grant accelerated approval for its breast cancer ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »